Client was a leader in electronic medical record indexing, working with major hospital systems to ensure continuity of care. With the implementation of new interoperability rules, it was imperative for the company to develop strategic growth options in adjacent markets. Client required consulting support to provide expertise outside of the hospital segment.

Conducted U.S. market assessment and reimbursement strategy for an imaging innovator pre-FDA clearance, helping position the company for regulatory approval and successful U.S. market entry.

Medication errors cause tens of thousands of deaths annually in the U.S. Existing alert systems produce too many false positives, leading to clinician fatigue and ignored warnings. The client developed an AI-driven platform that sharply improved accuracy but needed a business case and integration strategy? to navigate complex healthcare incentives and prove value to hospitals and payers.

The client sought to replace traditional invasive biopsies with a noninvasive, AI-driven imaging and analytics platform capable of real-time cancer detection. The technology showed strong promise across multiple cancers but faced a crowded diagnostics landscape, complex regulatory pathways, and questions about market entry strategy and investor appeal.

The client built an open-source marketplace connecting healthcare developers, researchers, and organizations to share and deploy data-driven applications. With hundreds of contributors and growing traction among developers, the company needed to convert community enthusiasm into enterprise demand among health systems, life-sciences firms, and payers. Leadership sought a scale-up strategy to attract institutional users and prepare for Series A fundraising.

When COVID-19 shut down workplaces, the client’s mobile vision-testing business evaporated overnight. They successfully repurposed their mobile centers to support pharmaceutical trials but were uncertain whether to build a long-term clinical-trials business once normal operations resumed.

New interoperability rules threatened to erode demand for the client’s core hospital indexing product. Leadership needed to gauge how much risk the regulation posed and to identify growth paths beyond hospitals.

The client planned to build in-store health clinics but lacked a digital bridge to unify customer health engagement. The innovation group sought guidance on how to design and prioritize digital offerings that complemented its physical assets.

Ransomware attacks had driven up insurance premiums and threatened coverage for member hospitals. The association needed a plan to protect members and restore insurer confidence.

A breakthrough technology promised faster, simpler disease-activity testing but clashed with the firm’s original complex platform. Board, founder, and management were deadlocked over which path to pursue.

A company that provided mobile vision centers for office workers switched to supporting clinical trials during the pandemic. With normalcy returning, the company needed help to decide whether to invest in building a clinical trials business for the long term.

A leading retailer had decided to enter the healthcare space, with a focus on in-person clinics and other physical assets. The Client’s innovation group sought support to develop and prioritize complementary digital offerings.

A remote patient monitoring (RPM) company that marketed to physician offices wanted to accelerate its growth by adding a consumer pay offering. Health Business Group conducted consumer market research, identified partnership opportunities, and developed a go to market plan.

A development-stage diagnostics company had developed a new technology to assess disease activity with a simple test. The technology had great potential, but pursuing it would be disruptive for the company.